Floatz logo

1,379 assets in Cancer

Therapeutic assets addressing Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Lavender Oil
Cancer
City of Hope Medical CenterN/AD (30)
Lidocaine Hydrochloride 2% For
Cancer
Imperial College LondonN/AD (30)
Ramifentanyl
Cancer
Ankara City Hospital BilkentN/AD (30)
Soluble Fluorescein
Cancer
Mayo ClinicN/AD (30)
Viosterol
Cancer
Jiuda ZhaoN/AD (30)
68Ga-FAPI-JNU
Cancer
Affiliated Hospital of Jiangnan UniversityN/AD (28)
Compound Ciwujia Granules
Cancer
Shanghai Municipal Hospital of Traditional Chinese MedicineN/AD (28)
CT-100 DiNaMo
Cancer
Click Therapeutics, Inc.N/AD (28)
Heparin
Cancer
H. Lee Moffitt Cancer Center and Research InstituteN/AD (28)
Recombinant Fsh
Cancer
University of California, San DiegoN/AD (28)
Vobramitamab Duocarmazine
Cancer
MacroGenicsP1D (28)
Bms-986466
Cancer
Bristol-Myers SquibbP1/2D (26)
gt307
Cancer
Grit BiotechnologyN/AD (26)
Pegylated-Interferon .Alfa. 2B (Peg-Ifn)
Cancer
The First Affiliated Hospital of Xiamen UniversityN/AD (26)
ft538
Cancer
Masonic Cancer Center, University of MinnesotaP1D (25)
afm24
Cancer
Affimed GmbHP1/2D (23)
Bgb-3245
Cancer
SpringWorks Therapeutics, Inc.P1/2D (23)
Trotabresib
Cancer
Bristol-Myers SquibbP1D (21)
100 μg ncp-il-22bp mrna
Cancer
West China HospitalP1NR ()
ak-1286
Cancer
Shanghai YingLi Pharmaceutical Co. Ltd.P1NR ()
Allogeneic Wtx-212C
Cancer
Zhejiang Provincial People's HospitalEarly P1NR ()
Anlotinib Hydrochloride Capsules
Cancer
Jinming YuP1NR ()
Asn-3186
Cancer
Jiangsu Yahong Meditech Co., Ltd aka AsierisP1/2NR ()
asp1893
Cancer
Astellas Pharma Global Development, Inc.P1NR ()
bc006
Cancer
Dragonboat Biopharmaceutical Company LimitedP1NR ()
cd44v6-specific car gene-engineered t cells
Cancer
Shenzhen Geno-Immune Medical InstituteP1/2NR ()
Cho-A04
Cancer
Cho Pharma Inc.P1/2NR ()
cm369
Cancer
Beijing InnoCare Pharma Tech Co., Ltd.P1NR ()
cs5007
Cancer
CStone PharmaceuticalsP1NR ()
cvl218
Cancer
Fujian Cancer HospitalP1/2NR ()
D3L-002
Cancer
D3 Bio (Wuxi) Co., LtdP1NR ()
Dat-1604
Cancer
Danatlas Pharmaceuticals Co., LtdP1NR ()
Edc-Kras Vaccine
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/ANR ()
fs-207
Cancer
Foresight Therapeutics (Hefei) Co., Ltd.P1NR ()
gh55
Cancer
Tyligand Bioscience (Shanghai) LimitedP1/2NR ()
hs-10529
Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1NR ()
hs-20105
Cancer
Hansoh BioMedical R&D CompanyP1/2NR ()
Icp-B208
Cancer
Beijing InnoCare Pharma Tech Co., Ltd.P1/2NR ()
Icp-B794
Cancer
Beijing InnoCare Pharma Tech Co., Ltd.P1NR ()
IL-12 GEMys
Cancer
National Cancer Institute (NCI)P1NR ()
imb071703
Cancer
Beijng Immunoah Pharma Tech Co., Ltd.P1NR ()
in10028
Cancer
InxMed (Shanghai) Co., Ltd.P1NR ()
Ivarmacitinib
Cancer
Fujian Cancer HospitalP2NR ()
jh021
Cancer
Biotech Pharmaceutical Co., Ltd.P1NR ()
Jnj-89862175
Cancer
Janssen Research & Development, LLCP1NR ()
kh801
Cancer
Beijing Kanghong Biopharmaceutical Co., Ltd.P1NR ()
kh815 for
Cancer
Chengdu Kanghong Biotech Co., Ltd.P1NR ()
Showing 1301 to 1350 of 1,379 assets
PreviousPage 27 of 28Next